Sex differences in dopamine- and vesicular monoamine-transporter functions

Area of Science:

• Neuroscience
• Pharmacology
• Neurobiology

Background:

• Men and women exhibit distinct patterns in methamphetamine (MA) use and physiological responses.
• These sex-based disparities in MA effects are also observable in preclinical animal models.
• Understanding the neurobiological underpinnings of these differences is crucial for targeted interventions.

Purpose of the Study:

• To investigate the roles of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) in mediating sex differences in response to methamphetamine (MA).
• To elucidate the functional characteristics of DAT and VMAT2 in male and female subjects.
• To determine how variations in DAT and VMAT2 activity contribute to differential MA effects.

Main Methods:

• Experiments focused on assessing dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) function in male and female subjects.
• Utilized superfused striatal tissue preparations to measure dopamine (DA) release and transporter activity.
• Employed DAT-blocking agent nomifensine and VMAT2-blocking agent reserpine to evaluate transporter function in vitro and in vivo.

Main Results:

• Females displayed higher dopamine transporter (DAT) activity, indicated by greater dopamine recovery and extracellular dopamine levels after nomifensine infusion.
• Methamphetamine-induced dopamine release was significantly higher in males, suggesting DAT activity alone does not explain sex differences.
• Females exhibited more efficient vesicular monoamine transporter 2 (VMAT2) function, evidenced by greater striatal dopamine depletion and extracellular dopamine levels following reserpine administration.

Conclusions:

• Significant sex differences exist in both dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) functioning.
• The interplay between DAT and VMAT2 activity in males and females likely underlies the observed disparities in methamphetamine (MA) response.
• These findings highlight the importance of considering sex as a biological variable in the neurobiology of stimulant action.